NKT sells Scandinavian Micro Biodevices A/S
NKT Holding has entered into an agreement concerning sale of NKT's life science company Scandinavian Micro Biodevices A/S (SMB) to Inverness Medical Switzerland GmbH, a wholly owned subsidiary of Inverness Medical Innovations, Inc., USA. With the sale of SMB, the plans to focus NKT's portfolio of development businesses on activities in the photonics field have now been carried out.
Under the new ownership SMB shall be continued as a wholly-owned subsidiary within the Inverness group, which develops, manufactures and markets consumer products, such as pregnancy tests and professional diagnostic products, such as strep tests. Inverness is strongly positioned in its main business areas in the United States, Europe and Japan.
The advanced process technology for manufacturing biochips and the know how related to handling biological samples on a micro-scale, both of which are foundations of SMB's core competency, possess significant future potential for Inverness.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.